Chemotherapy may be Helpful for Advanced Lung Cancer Patients

Conventional chemotherapy was associated with an improvement in the survival of patients with advanced non-small cell lung cancer, a new study found. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred treatment option for patients with advanced non-small cell lung cancer (NSCLC) who have mutations in the EGFR gene. These drug-sensitive mutations are found in about 10 percent of Western patients and almost 50 percent of Asian patients with NSCLC. However, ...